Pharmacist‐led transitions of care between hospitals, primary care clinics, and community pharmacies. Issue 3 (24th November 2021)

• Record Type: Journal Article
• Authors: Cossette, Benoit; Ricard, Geneviève; Poirier, Rolande; Gosselin, Suzanne; Langlois, Marie‐France; Imbeault, Philippe; Breton, Mylaine; Couturier, Yves; Sirois, Caroline; Lessard‐Beaudoin, Mélissa; Rodrigue, Claudie; Teasdale, Julie; Turcotte, Jean‐Philippe; Mallet, Louise
• Is Part Of: Journal of the American Geriatrics Society. Volume 70:Issue 3(2022)
• Page Start: 766
• Page End: 776
• Publication Date: 2021-11-24
• Subjects: medication management -- older adults -- pharmacist -- primary care clinics -- transitions of care; Geriatrics -- Periodicals; 618.97
• DOI: 10.1111/jgs.17575
• Languages: English
• ISSNs: 0002-8614

Abstract

Abstract: Background: Pharmacist‐led transitions of care (TOC) interventions have been described as some of the most promising interventions to reduce medication‐related harm (MRH) in older adults. This study analyzed the feasibility of pharmacist‐led TOC interventions between hospitals, multidisciplinary primary care clinics (PCC), and community pharmacies. Methods: Adults aged 65 years and older at risk of MRH in three regions of Quebec, Canada, with contrasting contexts of care based on university affiliation were recruited in this multicenter, single arm, and prospective intervention cohort. The hospital pharmacist developed the pharmaceutical care plan in collaboration with the hospital physician and transferred this plan with the hospitalization summary, at hospital discharge, to the PCC family physician and to the community and PCC pharmacists. A consultation with the community pharmacist was scheduled within seven days of hospital discharge and with the PCC pharmacist when appropriate. Feasibility outcomes included the time to complete the interventions and their location. Results: The 123 eligible patients had a mean age of 78.5 years, and 63.4% were females. The most frequent inclusion criterion was 10 medications or more, including one high‐risk medication for 90 patients (73%). Recruitment in one region was stopped after three months due to unsuccessful recruitment of key PCC. The hospital pharmacist interventions took a median of 165 min. The first consultations of the PCC and community pharmacists took a median of 15 and 50 min. Among the 96 patients with a post‐discharge pharmacist follow‐up, 23 (24.0%) had a consultation with a PCC pharmacist, with 65.2% of the consultations conducted at the PCC. The community pharmacists conducted a consultation with 88 patients (93%), with more than 70% of consultations conducted by phone. Conclusion: Our study showed the feasibility of pharmacist‐led TOC interventions between hospitals, PCC, and community pharmacies and detailed the novel role that PCC pharmacists played in optimizing TOC interventions.